|
- Makena® (hydroxyprogesterone caproate injection)
On April 6, 2023, the U S Food and Drug Administration (FDA) issued a final decision ordering the withdrawal of the approval of Makena FDA has stated that it recognizes that a limited supply of these drugs has already been distributed, including to physicians’ offices and pharmacies
- Giving moms an extra layer of personalized support through Makena Care . . .
Is Makena® (hydroxyprogesterone caproate injection) safe? You and your healthcare provider should consider the benefits and risks of therapy with Makena prior to deciding if Makena is right for you Makena should not be used if you: • Have now or have had a history of blood clots or other blood clotting problems
- AYUDE A DARLE A SU BEBÉ MÁS TIEMPO
¿Qué es MAKENA? Makena la ayuda a acercarse más al parto a término (progestágeno) que se receta para reducir el riesgo de volver a tener un bebé prematur
- （妊娠37周前），您有再次
Makena®(己酸羟孕酮注射液)安全吗? 在确定Makena是否适合您之前,您和医护人员应先考虑接受Makena的治疗有哪些益处和风险。 如果您有以下病症请勿使用Makena1: • 现在或过去有血凝块或其他凝血问题 • 现在或过去有乳腺癌或其他激素敏感性癌症
- Healthcare provider discussion guide
Makena single- and multi-dose vials (for intramuscular injection) Makena (NDC 64011-247-02) is supplied as 1 mL of a sterile preservative-free clear yellow solution in a single-dose glass vial
- GIÚP CHO EM BÉ QUÝ VỊ CÓ THÊM THỜI GIAN
Makena, phát âm là Ma-kin-a, là một loại thuốc kích thích tố (progestin) được bác sĩ cho toa dùng để giảm nguy cơ sinh non một lần nữa ở những phụ nữ1: • Đang có thai một con, và • Trước đây bất ngờ sinh ra một con quá sớm (trước 37 tuần)
- Uncategorized – Makena® (hydroxyprogesterone caproate injection)
On April 6, 2023, the U S Food and Drug Administration (FDA) issued a final decision ordering the withdrawal of the approval of Makena FDA has stated that it recognizes that a limited supply of these drugs has already been distributed, including to physicians’ offices and pharmacies
- كلفط حنم يف يدعاس ومني يك تقولا نم ديزملا
3O H H H لمحلا ةرتف للاخ مدلا Makena is a clear, yellow, sterile, non-pyrogenic solution for intramuscular injection Each 1 mL single dose vial contains hydroxyprogesterone caproate USP, 250 mg mL (25% w v), in castor oil USP (30 6% v v) and benzyl benzoate USP (46% v v)
|
|
|